|
1
|
Leon SA, Shapiro B, Sklaroff DM and Yaros
MJ: Free DNA in the serum of cancer patients and the effect of
therapy. Cancer Res. 37:646–650. 1977.PubMed/NCBI
|
|
2
|
Li L, Choi JY, Lee KM, Sung H, Park SK,
Oze I, Pan KF, You WC, Chen YX, Fang JY, et al: DNA methylation in
peripheral blood: A potential biomarker for cancer molecular
epidemiology. J Epidemiol. 22:384–394. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Aung KL, Board RE, Ellison G, Donald E,
Ward T, Clack G, Ranson M, Hughes A, Newman W and Dive C: Current
status and future potential of somatic mutation testing from
circulating free DNA in patients with solid tumours. Hugo J.
4:11–21. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Elshimali YI, Khaddour H, Sarkissyan M, Wu
Y and Vadgama JV: The clinical utilization of circulating cell free
DNA (CCFDNA) in blood of cancer patients. Int J Mol Sci.
14:18925–18958. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vedula RS and Lindsley RC: Measurement of
residual disease in acute myeloid leukemia. Curr Hematol Malig Rep.
12:574–581. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hourigan CS, Gale RP, Gormley NJ,
Ossenkoppele GJ and Walter RB: Measurable residual disease testing
in acute myeloid leukaemia. Leukemia. 31:1482–1490. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Venditti A, Del Poeta G, Buccisano F,
Tamburini A, Cox-Froncillo MC, Aronica G, Bruno A, Del Moro B,
Epiceno AM, Battaglia A, et al: Prognostic relevance of the
expression of Tdt and CD7 in 335 cases of acute myeloid leukemia.
Leukemia. 12:1056–1063. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kyoda K, Nakamura S, Matano S, Ohtake S
and Matsuda T: Prognostic significance of immunoglobulin heavy
chain gene rearrangement in patients with acute myelogenous
leukemia. Leukemia. 11:803–806. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yen CC, Liu JH, Wang WS, Chiou TJ, Fan FS
and Chen PM: Prognostic significance of immunoglobulin and T cell
receptor gene rearrangements in patients with acute myeloid
leukemia: Taiwan experience. Leuk Lymphoma. 35:179–187. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kwok S and Higuchi R: Avoiding false
positives with PCR. Nature. 339:237–238. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kosari F, Shishehbor F, Saffar H and
Sadeghipour A: PCR-based clonality analysis in diffuse large B-cell
lymphoma using BIOMED-2 primers of IgH (FR3) on formalin-fixed
paraffin-embedded tissue. Arch Iran Med. 16:526–529.
2013.PubMed/NCBI
|
|
12
|
van der Velden VH, Cazzaniga G, Schrauder
A, Hancock J, Bader P, Panzer-Grumayer ER, Flohr T, Sutton R, Cave
H, Madsen HO, et al: Analysis of minimal residual disease by Ig/TCR
gene rearrangements: Guidelines for interpretation of real-time
quantitative PCR data. Leukemia. 21:604–611. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Döhner H, Weisdorf DJ and Bloomfield CD:
Acute myeloid leukemia. N Engl J Med. 373:1136–1152. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Liu QF, Xu LP, Liu KY, Zhang XH,
Ma X, Fan ZP, Wu DP and Huang XJ: Haploidentical vs
identical-sibling transplant for AML in remission: A multicenter,
prospective study. Blood. 125:3956–3962. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kuhlmann JD, Schwarzenbach H, Wimberger P,
Poetsch M, Kimmig R and Kasimir-Bauer S: LOH at 6q and 10q in
fractionated circulating DNA of ovarian cancer patients is
predictive for tumor cell spread and overall survival. BMC Cancer.
12:3252012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Salvianti F, Pinzani P, Verderio P,
Ciniselli CM, Massi D, De Giorgi V, Grazzini M, Pazzagli M and
Orlando C: Multiparametric analysis of cell-free DNA in melanoma
patients. PLoS One. 7:e498432012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mussolin L, Burnelli R, Pillon M, Carraro
E, Farruggia P, Todesco A, Mascarin M and Rosolen A: Plasma
cell-free DNA in paediatric lymphomas. J Cancer. 4:323–329. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Poopak B, Saki N, Purfatholah AA,
Najmabadi H, Mortazavi Y, Arzanian MT, Khosravipour G, Haghnejad F,
Salari F and Shahjahani M: Pattern of immunoglobulin and T-cell
receptor-δ/γ gene rearrangements in Iranian children with
B-precursor acute lymphoblastic leukemia. Hematology. 19:259–266.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kim Y, Choi YD, Choi C and Nam JH:
Diagnostic utility of a clonality test for lymphoproliferative
diseases in koreans using the BIOMED-2 PCR assay. Korean J Pathol.
47:458–465. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Garcia-Castillo H, Leal-Ugarte E, Lazareno
Ortiz PC, Barrera-Chairez E, Rosales-Garcia VH and Barros-Núñez P:
Detection of monoclonal IGH rearrangements in circulating cells
from healthy first-degree relatives of patients with multiple
myeloma. Med Oncol. 31:9002014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang J, Sun X, Gong X, He Z, Chen L, Qiu
X and Yin CC: Rearrangement and expression of the immunoglobulin
µ-chain gene in human myeloid cells. Cell Mol Immunol. 11:94–104.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Haslina Noor MN, Marini R, Rosnah B,
Shafini MY, Haslindawani Wan WM, Nazri Mohd H, Salamah G, Hasnan J
and Rosline H: Immunoglobulin heavy chain gene rearrangement in non
b-cell haematological malignancies. West Indian Med J. 62:701–704.
2013.PubMed/NCBI
|
|
23
|
Cen L, Jiang Y, Chen T, Zhang Y and Zhou
M: Clinical feature and cytogenetic analysis of 80 patients with
acute monocytic leukemia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi.
31:206–209. 2014.(In Chinese). PubMed/NCBI
|
|
24
|
Boeckx N, Willemse MJ, Szczepanski T, van
der Velden VH, Langerak AW, Vandekerckhove P and van Dongen JJ:
Fusion gene transcripts and Ig/TCR gene rearrangements are
complementary but infrequent targets for PCR-based detection of
minimal residual disease in acute myeloid leukemia. Leukemia.
16:368–375. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qiu X, Sun X, He Z, Huang J, Hu F, Chen L,
Lin P, You MJ, Medeiros LJ and Yin CC: Immunoglobulin gamma heavy
chain gene with somatic hypermutation is frequently expressed in
acute myeloid leukemia. Leukemia. 27:92–99. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cilloni D, Renneville A, Hermitte F, Hills
RK, Daly S, Jovanovic JV, Gottardi E, Fava M, Schnittger S, Weiss
T, et al: Real-time quantitative polymerase chain reaction
detection of minimal residual disease by standardized WT1 assay to
enhance risk stratification in acute myeloid leukemia: A European
LeukemiaNet study. J Clin Onco. 27:5195–5201. 2009. View Article : Google Scholar
|
|
27
|
Gianfaldoni G, Mannelli F, Ponziani V,
Longo G, Bencini S, Bosi A and Vannucchi AM: Early reduction of WT1
transcripts during induction chemotherapy predicts for longer
disease free and overall survival in acute myeloid leukemia.
Haematologica. 95:833–836. 2010. View Article : Google Scholar : PubMed/NCBI
|
